1. Case report {#sec1}
==============

A 61 year old man that underwent cataract surgery four years ago, has arrived to the ophthalmology emergency room because of blurry vision. His visual acuity (VA) was 20/50 and the intra ocular pressure (IOP) was 30 mmHg. In the anterior chamber (AC), red blood cells were found. Iris transillumination defects in the shape of one piece intra ocular lens (1P-IOL) were observed ([Fig. 1](#fig1){ref-type="fig"}A--B, Arrow-Haptic, Asterisk-Optic). The SN60WF-Aspheric-Alcon-IQ-1P-IOL was in the sulcus. Uveitis Glaucoma Hyphema (UGH) syndrome with vitreous hemorrhage (VH) was diagnosed so he got steroidal and anti glaucoma drops and referred to an exchange IOL surgery.Fig. 1A--B: Iris transillumination defects in the shape of one piece intra ocular lens (\\ Arrow-Haptic, Asterisk-Optic.Fig. 1

IOL exchanges were performed under topical anesthesia. A main clear corneal and a side incision were made, and the anterior chamber was filled with ophthalmic viscoelastic device (OVD). The 1P-IOL was extracted from the main wound in dissected body. After filling the chambers with OVD, the AC lens was implanted. OVD was completely removed.

Ten day post operation, his VA was 20/32, the IOP was normalized and the ACIOL was in place.

2. Discussion {#sec2}
=============

In 1978, Ellingson introduced firstly the syndrome Uveitis Glaucoma Hyphema (UGH).[@bib1] The condition presents weeks to months after cataract extraction and AC-IOL[@bib2] or posterior chamber IOL implantation[@bib3] and is characterized by recurrent episodes of AC inflammation, increased IOP and hyphema. It is thought to be caused by IOL chafing of the iris and angle structures, resulting a mechanical trauma of the tissue, release of iris pigment that cause to inflammation, increased IOP, and microhyphema.

In this case report we present a case of ACIOL that was implanted in the anterior chamber causing to severe iris chafing with specific IOL shape iris transillumination imprint and this probably caused to UGH and VH. Chang et al. recommended that 1P-acrylic IOl shoud not be placed in the sulcus.[@bib4] However, it is still, on our opinion, that ophthalmic surgeons are periodically reminded of this.

3. Conclusion {#sec3}
=============

1P Alcon IQ IOL is designed specifically for implantation in the bag. Placement in the sulcus 1P Alcon IQ IOL should be avoided.
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